Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

pegdinetanib

A highly specific, synthetic peptide vascular endothelial growth factor receptor-2 (VEGFR-2) antagonist with potential antiangiogenic activity. Derived from human fibronectin with a proprietary protein engineering process, pegdinetanib may block the activation of VEGFR-2 by all known activating ligands, thereby inhibiting the growth of new tumor blood vessels.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:VEGFR-2 inhibitor peptide CT-322
US brand name:Angiocept
Code name:CT-322
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search